MA53914A - Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton - Google Patents

Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton

Info

Publication number
MA53914A
MA53914A MA053914A MA53914A MA53914A MA 53914 A MA53914 A MA 53914A MA 053914 A MA053914 A MA 053914A MA 53914 A MA53914 A MA 53914A MA 53914 A MA53914 A MA 53914A
Authority
MA
Morocco
Prior art keywords
bruton
tyrosine kinase
kinase inhibitors
crystalline polymorphs
polymorphs
Prior art date
Application number
MA053914A
Other languages
English (en)
French (fr)
Inventor
Chaomin Li
Yiqing Lin
Daniel B Patience
Anton Peterson
Kalyan Vasudevan
Fengmei Zheng
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of MA53914A publication Critical patent/MA53914A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA053914A 2018-10-15 2019-10-15 Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton MA53914A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862745741P 2018-10-15 2018-10-15

Publications (1)

Publication Number Publication Date
MA53914A true MA53914A (fr) 2021-08-25

Family

ID=68426868

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053914A MA53914A (fr) 2018-10-15 2019-10-15 Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton

Country Status (5)

Country Link
US (1) US11820760B2 (cg-RX-API-DMAC7.html)
EP (1) EP3866926A1 (cg-RX-API-DMAC7.html)
JP (1) JP7476214B2 (cg-RX-API-DMAC7.html)
MA (1) MA53914A (cg-RX-API-DMAC7.html)
WO (1) WO2020081514A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2025013208A (es) * 2023-05-05 2026-02-03 Biogen Ma Inc Inhibidor de btk para el tratamiento de la esclerosis múltiple

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
BR112015007513A2 (pt) 2012-10-26 2017-07-04 Hoffmann La Roche inibidores de tirosina quinase de bruton
US10329270B2 (en) * 2013-10-21 2019-06-25 Merck Patent Gmbh Heteroaryl compounds as BTK inhibitors and uses thereof
HRP20181109T1 (hr) 2013-12-11 2018-11-02 Biogen Ma Inc. Spojevi biarila korisni za liječenje ljudskih bolesti u onkologiji, neurologiji i imunologiji
MA42510A (fr) 2015-06-10 2018-06-06 Biogen Ma Inc Formes et compositions d'inhibiteurs biaryles de la tyrosine kinase de bruton
RS65386B1 (sr) * 2017-04-14 2024-04-30 Biogen Ma Inc Benzoazepinski analozi kao sredstva za inhibiciju brutonove tirozin kinaze
WO2019222101A1 (en) 2018-05-14 2019-11-21 Biogen Ma Inc. Inhibiting agents for bruton's tyrosine kinase

Also Published As

Publication number Publication date
US11820760B2 (en) 2023-11-21
WO2020081514A1 (en) 2020-04-23
EP3866926A1 (en) 2021-08-25
US20210387972A1 (en) 2021-12-16
WO2020081514A9 (en) 2020-05-22
JP7476214B2 (ja) 2024-04-30
JP2022502516A (ja) 2022-01-11

Similar Documents

Publication Publication Date Title
EP3870178A4 (en) Crystalline forms of mnk inhibitors
MA51619A (fr) Inhibiteurs de la protéine kinase dépendante de l'adn
EP3399968A4 (en) SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANES OF EGFR-TYROSINE KINASE
EP3873477A4 (en) CYCLIN DEPENDENT KINASE 7 (CDK7) INHIBITOR
DK3265084T3 (da) Farmaceutiske formuleringer af Bruton's tyrosinkinase-hæmmer
EP3492462A4 (en) AMINOPYRIMIDIN COMPOUND FOR INHIBITING PROTEINTYROSINKINASE ACTIVITY
ZA201903932B (en) Imidazopyrazine inhibitors of bruton's tyrosine kinase
IL255831A (en) Inhibitors of bruton's tyrosine kinase
IL270693A (en) Glucuronide prodrugs of janus kinase inhibitors
EP3405192A4 (en) BRUTON TYROSINE KINASE HEMMER
EP3740206A4 (en) INHIBITORS OF THE CYCLINE-DEPENDENT KINASE 7 (CDK7)
EP3414234A4 (en) BRUTON TYROSINE KINASE HEMMER
MA41828A (fr) Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton
MA41350A (fr) Synthèse d'un inhibiteur de la tyrosine kinase de bruton
ZA201903694B (en) Inhibitors of bruton's tyrosine kinase
MA42510A (fr) Formes et compositions d'inhibiteurs biaryles de la tyrosine kinase de bruton
MA52629A (fr) Agents inhibiteurs de la tyrosine kinase de bruton
MA42509A (fr) Formes d'adipate et compositions d'inhibiteurs de biaryle de la tyrosine kinase de bruton
EP3962908A4 (en) HETEROCYCLIC INHIBITORS OF TYROSINE KINASE
EP3969111A4 (en) Inhalable formulations for kinase inhibition
EP3730483A4 (en) CLASS OF PYRIMIDINE DERIVATIVES AS CINEMA INHIBITORS
EP3765008A4 (en) HETEROCYCLIC INHIBITORS OF THE ATR KINASE
IL269152A (en) Broughton's kinase designers
EP3833778A4 (en) MULTIPLEX DETECTION OF NUCLEIC ACIDS
IL287745A (en) Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor